Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA.17 Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Nitriles
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Tamoxifen
  • Triazoles

abstract

  • Letrozole after tamoxifen is well-tolerated and improves both disease-free and distant disease-free survival but not overall survival, except in node-positive patients.

publication date

  • September 7, 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1093/jnci/dji250

PubMed ID

  • 16145047

Additional Document Info

start page

  • 1262

end page

  • 71

volume

  • 97

number

  • 17